Oculis Holding AG (NASDAQ:OCSAW – Get Free Report) saw a large decrease in short interest in June. As of June 30th, there was short interest totaling 4,485 shares, a decrease of 43.2% from the June 15th total of 7,902 shares. Based on an average daily volume of 4,538 shares, the short-interest ratio is currently 1.0 days.
Oculis Stock Down 4.2%
Shares of OCSAW stock traded down $0.20 during mid-day trading on Thursday, reaching $4.57. 17,274 shares of the company were exchanged, compared to its average volume of 6,032. Oculis has a fifty-two week low of $3.63 and a fifty-two week high of $22.64. The business’s 50 day simple moving average is $9.61 and its 200 day simple moving average is $13.12.
Oculis Company Profile
Oculis SA is a clinical‐stage biopharmaceutical company focused on developing disease‐modifying therapies for serious eye diseases. Utilizing its proprietary ocular formulation technologies, the company is advancing a pipeline of small‐molecule product candidates designed for topical or injectable delivery. Lead programs include OCS-01, a topical eye drop candidate for diabetic macular edema, and OCS-02, targeting diabetic retinopathy. Oculis also has OCS-05 in development for optic neuropathies and other retinal disorders, reflecting its commitment to addressing a broad spectrum of unmet needs in ophthalmology.
Founded in 2016 and headquartered in Geneva, Switzerland, Oculis operates research and development facilities in Europe and the United States.
Featured Stories
- Five stocks we like better than Oculis
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Oculis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oculis and related companies with MarketBeat.com's FREE daily email newsletter.
